Keqiang Chen Selected Research

GTP-Binding Proteins (G-Protein)

1/2021	Leukocyte chemotactic receptor Fpr1 protects against aging-related posterior subcapsular cataract formation.
10/2020	The G-protein-coupled chemoattractant receptor Fpr2 exacerbates neuroglial dysfunction and angiogenesis in diabetic retinopathy.
1/2020	The G-Protein Coupled Formyl Peptide Receptors and Their Role in the Progression of Digestive Tract Cancer.
2/2016	Formylpeptide receptor 1 mediates the tumorigenicity of human hepatocellular carcinoma cells.
1/2016	The G-protein coupled chemoattractant receptor FPR2 promotes malignant phenotype of human colon cancer cells.
12/2011	Chemoattractant receptors as pharmacological targets for elimination of glioma stem-like cells.
9/2011	Annexin 1 released by necrotic human glioblastoma cells stimulates tumor cell growth through the formyl peptide receptor 1.
8/2009	Synergy of TRIF-dependent TLR3 and MyD88-dependent TLR7 in up-regulating expression of mouse FPR2, a promiscuous G-protein-coupled receptor, in microglial cells.
2/2009	Regulation of the leucocyte chemoattractant receptor FPR in glioblastoma cells by cell differentiation.
6/2008	Cooperation between NOD2 and Toll-like receptor 2 ligands in the up-regulation of mouse mFPR2, a G-protein-coupled Abeta42 peptide receptor, in microglial cells.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Keqiang Chen Research Topics

Disease

25	Neoplasms (Cancer) 03/2022 - 08/2005
20	Inflammation (Inflammations) 01/2021 - 02/2006
10	Carcinogenesis 01/2022 - 06/2007
8	Glioblastoma (Glioblastoma Multiforme) 09/2019 - 04/2006
7	Muscle Cramp (Cramp) 01/2021 - 06/2013
7	Alzheimer Disease (Alzheimer's Disease) 08/2009 - 11/2005
6	Neoplasm Metastasis (Metastasis) 01/2021 - 05/2008
6	Glioma (Gliomas) 11/2012 - 04/2006
5	Infections 03/2022 - 10/2007
4	Colitis 11/2020 - 10/2016
2	Bacterial Infections (Bacterial Infection) 01/2021 - 02/2006
2	Fatty Liver 04/2017 - 03/2016
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2017 - 02/2006
1	Communicable Diseases (Infectious Diseases) 03/2022
1	Lung Abscess 03/2022
1	Partial Epilepsies (Epilepsy, Partial) 01/2022
1	Cataract (Cataracts) 01/2021
1	Rupture 01/2021
1	Eye Infections 01/2021
1	Diabetic Retinopathy (Retinopathy, Diabetic) 10/2020
1	Stomach Neoplasms (Stomach Cancer) 01/2019
1	Body Weight (Weight, Body) 01/2019
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2018
1	Dysbiosis 01/2018
1	Lung Neoplasms (Lung Cancer) 12/2017
1	Type 2 Diabetes Mellitus (MODY) 12/2017
1	Septic Shock (Toxic Shock Syndrome) 10/2017
1	Atherosclerosis 04/2017
1	Atherosclerotic Plaque (Atheroma) 04/2017
1	Protein Deficiency 01/2017
1	Non-alcoholic Fatty Liver Disease 03/2016
1	Liver Neoplasms (Liver Cancer) 02/2016
1	Hepatocellular Carcinoma (Hepatoma) 02/2016
1	Colonic Neoplasms (Colon Cancer) 01/2016
1	Sepsis (Septicemia) 04/2015
1	Chronic Disease (Chronic Diseases) 03/2015
1	Lung Injury 01/2014
1	Wounds and Injuries (Trauma) 01/2014

Drug/Important Bio-Agent (IBA)

15	Formyl Peptide Receptors (Formyl Peptide Receptor)IBA 01/2021 - 11/2005
14	GTP-Binding Proteins (G-Protein)IBA 01/2021 - 12/2005
13	Peptides (Polypeptides)IBA 11/2020 - 12/2005
10	Chemotactic FactorsIBA 01/2020 - 02/2006
8	Proteins (Proteins, Gene)FDA Link 12/2017 - 04/2006
6	CathelicidinsIBA 01/2021 - 06/2014
6	LigandsIBA 01/2016 - 08/2009
6	Amyloid beta-PeptidesIBA 08/2009 - 12/2005
4	Antimicrobial PeptidesIBA 01/2021 - 01/2018
4	ChemokinesIBA 04/2018 - 01/2013
3	Anti-Bacterial Agents (Antibiotics)IBA 03/2022 - 01/2018
3	EndotoxinsIBA 03/2016 - 03/2015
3	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 11/2012 - 04/2006
3	Epidermal Growth Factor (EGF)IBA 08/2008 - 06/2007
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2021
2	Dextran SulfateIBA 01/2018 - 04/2013
2	AzoxymethaneIBA 01/2018 - 04/2013
2	ErbB Receptors (EGF Receptor)IBA 12/2017 - 06/2007
2	Pathogen-Associated Molecular Pattern MoleculesIBA 12/2017 - 10/2011
2	Apolipoproteins E (ApoE)IBA 04/2017 - 01/2017
2	ApolipoproteinsIBA 04/2017 - 03/2016
2	CollagenIBA 04/2017 - 02/2006
2	CalciumIBA 02/2016 - 09/2007
2	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2014 - 01/2013
2	Messenger RNA (mRNA)IBA 01/2014 - 01/2013
2	AnnexinsIBA 11/2012 - 09/2011
2	Toll-Like Receptors (Toll-Like Receptor)IBA 10/2011 - 10/2007
2	AgarIBA 09/2011 - 02/2009
2	Tyrosine (L-Tyrosine)FDA Link 08/2008 - 06/2007
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2008 - 09/2007
2	Lipoxygenase InhibitorsIBA 09/2007 - 04/2006
2	nordyIBA 09/2007 - 04/2006
2	N-Formylmethionine Leucyl-PhenylalanineIBA 06/2007 - 04/2006
1	Serine Proteases (Serine Protease)IBA 01/2022
1	Levetiracetam (Keppra)FDA LinkGeneric 01/2022
1	Oxcarbazepine (Trileptal)FDA LinkGeneric 01/2022
1	TrypsinIBA 01/2022
1	MucinsIBA 01/2021
1	LipopolysaccharidesIBA 01/2021
1	Peptide Hydrolases (Proteases)FDA Link 01/2021
1	Glucose (Dextrose)FDA LinkGeneric 09/2019
1	Growth Factor ReceptorsIBA 09/2019
1	Transcription Factors (Transcription Factor)IBA 01/2019
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2019
1	Dextrans (Dextran)FDA Link 01/2019
1	Pharmaceutical PreparationsIBA 01/2019
1	MetallothioneinIBA 01/2019
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2018
1	Tyrosine Kinase InhibitorsIBA 12/2017
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 12/2017
1	Metformin (Glucophage)FDA LinkGeneric 12/2017
1	Niacin (Nicotinic Acid)FDA LinkGeneric 10/2017
1	LipidsIBA 04/2017
1	ursodoxicoltaurineIBA 10/2016
1	Interleukin-8 (Interleukin 8)IBA 02/2016
1	CCR2 ReceptorsIBA 06/2013
1	Chemokine ReceptorsIBA 06/2013
1	AntigensIBA 01/2013

Therapy/Procedure

4	Therapeutics 12/2017 - 12/2011
1	Punctures 04/2015
1	Ligation 04/2015
1	Transplantation 01/2013